Clinicopathological features and management of IgM multiple myeloma and Waldenstrom macroglobulinemia

Waldenström macroglobulinemia (WM) is the most common malignancy associated with an IgM paraprotein, but in rare cases, a clonal IgM may be the result of IgM multiple myeloma (IgM-MM). Although there are some overlapping features associated with these two entities, there are specific characteristics that can help differentiate IgM-MM from WM. In each patient a thorough clinical, pathologic, and genomic evaluation is required to distinguish these conditions and allow for accurate diagnosis and appropriate treatment.

Authors

Institutions

Publication Details

Journal
Leukemia & lymphoma/Leukemia and lymphoma
Published
2026-01-21
DOI
https://doi.org/10.1080/10428194.2026.2616331
Primary Topic
Chronic Lymphocytic Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinicopathological features and management of IgM multiple myeloma and Waldenstrom macroglobulinemia

Zachary R. Hunter, Andrew R. Branagan, JJ Castillo, Shayna Sarosiek et al.
Leukemia & lymphoma/Leukemia and lymphoma
Chronic Lymphocytic Leukemia Research
article

Clinicopathological features and management of IgM multiple myeloma and Waldenstrom macroglobulinemia

Zachary R. Hunter, Andrew R. Branagan, JJ Castillo, Shayna Sarosiek, Steven P. Treon
article en

Abstract

Waldenström macroglobulinemia (WM) is the most common malignancy associated with an IgM paraprotein, but in rare cases, a clonal IgM may be the result of IgM multiple myeloma (IgM-MM). Although there are some overlapping features associated with these two entities, there are specific characteristics that can help differentiate IgM-MM from WM. In each patient a thorough clinical, pathologic, and genomic evaluation is required to distinguish these conditions and allow for accurate diagnosis and appropriate treatment.

Leukemia & lymphoma/Leukemia and lymphoma
Massachusetts General Hospital (US), Dana-Farber Cancer Institute (US)
Good health and well-being
Openalex Percentile: Top 81%
Chronic Lymphocytic Leukemia Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.